Director Peter Kelogg Shoots Up 1.26 Million Mercer Shares in Insider Buying Surge Amid 77% Stock Decline

Insider Buying Frenzy at Mercer International

Recent filings show that director Peter K. Kelogg has added 300 000 shares to his position in a single day – 43 000 shares at $0.84, 57 000 at $0.88 and 200 000 at $0.88 – bringing his total to roughly 1.26 million shares. The cumulative trade cost of about $0.25 million represents a 0.3 % purchase of the outstanding 42 million‑share float, a notable move in a company whose share price has trended sharply lower over the last year.

What does this mean for investors? Kelogg’s purchases come amid a broader pattern of insider buying that has been steadily increasing since late 2025. When a director adds to a position in a company that has suffered a 77 % annual decline and is trading near its 52‑week low, it can signal confidence that the company’s fundamentals—especially its high‑quality pulp production and emerging bio‑energy side—are undervalued. For equity holders, the uptick may provide a short‑term catalyst, but the volatility in the paper sector and the company’s negative P/E ratio caution against a blind chase of price moves.

Kelogg’s trading profile Between November 2025 and May 2026, Kelogg has executed at least 50 purchases of common stock, with a cumulative buying volume of more than 2.5 million shares. His trades are typically priced close to the market, ranging from $1.56 to $3.38, and he has never sold any shares during this period. The consistency of his activity—especially the recent large purchase when the stock was near its low—suggests a long‑term view and a willingness to hold through the sector’s cyclical swings. His holdings, now exceeding 1.26 million shares, account for roughly 3 % of the total shares outstanding, a significant voting stake for a director.

Implications for the company’s future Mercer’s business model—bleached softwood pulp and renewable bio‑electricity—provides a dual revenue stream that could cushion the company against commodity price swings. Kelogg’s continued investment aligns with the company’s stated focus on unlocking value from its asset portfolio, as seen in recent cash inflows from the sale of minor investments. If the company can leverage its bio‑electricity operations and improve operational efficiency, the stock could recover from its current trough. However, investors should remain vigilant: the paper industry continues to face regulatory and environmental headwinds, and the company’s negative earnings multiple indicates that profitability remains a challenge.

Bottom line Peter Kelogg’s latest bulk purchase is a positive insider signal, especially given the director’s history of consistent buying and the company’s strategic diversification. For investors, the trade offers an opportunity to add shares at a low price while the market digests the fundamentals. Yet, caution is warranted given the sector’s volatility and the company’s ongoing profitability concerns.